Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia

Chronic myeloid leukemia (CML) is a myeloproliferative disease characterized by the presence of BCR/ABL fusion gene in leukemic cells, which promotes uncontrolled cell proliferation. Up to 20% of CML patients show primary resistance or non-optimal response to tyrosine kinase inhibitor (TKI) therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Lavrov, Alexander V., Ustaeva, Oksana A., Adilgereeva, Elmira P., Smirnikhina, Svetlana A., Chelysheva, Ekaterina Y., Shukhov, Oleg A., Shatokhin, Yuriy V., Mordanov, Sergey V., Turkina, Anna G., Kutsev, Sergey I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597128/
https://www.ncbi.nlm.nih.gov/pubmed/28902850
http://dx.doi.org/10.1371/journal.pone.0182901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597128/
https://www.ncbi.nlm.nih.gov/pubmed/28902850
http://dx.doi.org/10.1371/journal.pone.0182901

Ejemplares similares